You are here

Article Text

Article menu
Download PDFPDF
Case Reports: Unusual presentation of more common disease/injury
Secondary open-angle glaucoma following YAG-laser vitreolysis
  1. Ewout de Vries1,
  2. Chenar Faraj1,
  3. Feike Gerbrandy2 and
  4. Caroline Hulsman1
  1. 1Ophthalmology, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands
  2. 2Floater laser Clinic, OMC Amstelland, Diemen, The Netherlands
  1. Correspondence to Dr Ewout de Vries; ewoutwilcodevries{at}hotmail.com

Abstract

We report a case of a man in his 50s who developed open-angle glaucoma following neodymium-doped yttrium aluminium garnet (YAG) laser vitreolysis. Despite attempts to control the pressure with topical medication and selective laser trabeculoplasty (SLT), surgical intervention using a Baerveldt glaucoma valve (BGV) was needed after which the intraocular pressure was controlled successfully. This rare but serious complication highlights the fact that in certain cases long-term monitoring of intraocular pressure is necessary following laser vitreolysis.

  • Glaucoma
  • Ophthalmology
  • Visual pathway

https://doi.org/10.1136/bcr-2022-248937

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Contributors Dr EdV has collected data and written the article. Mr CF has helped with figures and writing the article. Dr FG has helped with data collection and writing the article. Dr CH has helped with writing and reviewing the article.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

    • Competing interests None declared.

    • Provenance and peer review Not commissioned; externally peer reviewed.